A Dose Ranging Effect of Preoperative Diphenhydramine on Postoperative Quality of Recovery After Ambulatory Surgery

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Gildasio De Oliveira, Northwestern University
ClinicalTrials.gov Identifier:
NCT01451762
First received: September 20, 2011
Last updated: April 8, 2013
Last verified: April 2013

September 20, 2011
April 8, 2013
September 2011
September 2012   (final data collection date for primary outcome measure)
Quality of Recovery 40 at 24 hours [ Time Frame: 24 hours post operatively ] [ Designated as safety issue: No ]
The use of preoperative diphenhydramine will decrease postoperative pain by blocking histamine induced hyperalgesia and provide a better quality of recovery to patients after ambulatory surgery.
Same as current
Complete list of historical versions of study NCT01451762 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
A Dose Ranging Effect of Preoperative Diphenhydramine on Postoperative Quality of Recovery After Ambulatory Surgery
A Dose Ranging Effect of Preoperative Diphenhydramine on Postoperative Quality of Recovery After Ambulatory Surgery

Pain after ambulatory surgery remains an unsolved problem in The United States and Europe. It is associated with delayed hospital discharge and it can result to an increased opioid consumption with adverse side effects. The concept of multimodal analgesic technique was introduced more than 15 years ago and several techniques have been studied over the years including non steroidal antiinflammatory drugs (NSAIDs), acetaminophen, gabapentoids, ketamine, local and regional anesthetic techniques. Histamine can have effects on polymodal nociceptors and C-fibers, producing pain which is further increased by neurogenically mediated release of substance P from afferent pain fibers. Several non-selective or H1 -selective histamine receptors antagonists have been demonstrated in animal models and clinical pain. Chia et al demonstrated that preoperative promethazine had opioid sparing properties without adverse sedative effects in patients undergoing abdominal hysterectomy.

Diphenhydramine is an anti-histamine drug who has been found to be effective in reducing postoperative nausea and vomiting after ambulatory surgery but its effects on postoperative pain and other important outcomes after ambulatory surgery such as time to meet discharge criteria have not being studied.

The MQOR 40 is a validated instrument that was specifically design to evaluate patient recovery after anesthesia and surgery. This instrument can be particularly valid to examine interventions which affect different spheres of patient recovery as is the case of diphenhydramine. The objective of this study is to determine a dose response effect of preoperative diphenhydramine on postoperative quality of recovery after ambulatory surgery. The use of preoperative diphenhydramine can improve patient's quality of recovery, decrease postoperative pain, opioid consumption and opioid related side effects after ambulatory surgery.

The research question: Does a preoperative dose of diphenhydramine improve postoperative quality of recovery after ambulatory surgery? The hypothesis of this study is that preoperative diphenhydramine will improve postoperative pain, Postoperative nausea and vomiting (PONV), sleep which will translate in a better overall quality of recovery.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
  • Surgery
  • Pain
  • Drug: .9 normal saline
    .9 normal saline administered before surgery.
  • Drug: 25 mg diphenhydramine IV
    25 mg diphenhydramine IV administered before surgery
  • Drug: 50 mg diphenhydramine IV
    50 mg diphenhydramine administered IV before surgery
  • Placebo Comparator: Placebo
    .9 normal saline IV
    Intervention: Drug: .9 normal saline
  • Active Comparator: 25 mg diphenhydramine IV
    25 mg diphenhydramine IV administered before surgery
    Intervention: Drug: 25 mg diphenhydramine IV
  • Active Comparator: 50 mg diphenhydramine IV
    50 mg diphenhydramine IV administered before surgery
    Intervention: Drug: 50 mg diphenhydramine IV

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
85
September 2012
September 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age 18-64 years
  • Patients undergoing ambulatory surgery
  • ASA PS I, II.

Exclusion Criteria:

  • Chronic opioid use
  • pregnant patient or lactating patients
  • allergy to diphenhydramine
  • glaucoma
  • uncontrolled hypertension
  • asthma
  • hyperthyroidism
  • cardiovascular disease
Female
18 Years to 64 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01451762
STU00044695
No
Gildasio De Oliveira, Northwestern University
Northwestern University
Not Provided
Principal Investigator: Gildasio De Oliveira, MD Northwestern University
Northwestern University
April 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP